Filipīnas - angļu - FDA (Food And Drug Administration)

united douglas pharm philippines inc - multivitamins , minerals , herbs - soft capsule - each soft gel capsule contains: retinol acetate (vitamin a)-5,000i.u. ergocalciferol (vitamin d2)-400i.u ascorbic acid (vitamin c)-60.00mg tocopherol acetate (vitamin e)-45.00mg nicotinamide (vitamin b3)-20.00mg calcium pantothenate (vitamin b5)-15.30mg thiamine nitrate (vitamin b1)-2.00mg riboflavin (vitamin b2) -2.00mg . pyridoxin hydrochloride (vitamin b6)-2.00mg cyanocobalamin (vitamin b12)-6mcg magnesium-66.34mg iron (equivalent to 54.76mg ferrous fumarate)-18mg zinc (equivalent to 5mg zinc oxide)-4.00mg copper (equivalent to 7.86mg cupric sulfate)-2.00mg panax ginseng c.a. meyer (fam. araliaceae) roots-40.00mg aloe ferox miller (asphodelaceae) leaves -5.00mg

Īrija - angļu - HPRA (Health Products Regulatory Authority)

ayrton saunders ltd - zinc oxide; dimeticone 350 - cutaneous spray, solution - 12.5%w/w + 1.04 percent weight/weight - zinc products

Eiropas Savienība - angļu - EMA (European Medicines Agency)

ipsen pharma - mecasermin - laron syndrome - pituitary and hypothalamic hormones and analogues - for the long-term treatment of growth failure in children and adolescents with severe primary insulin-like-growth-factor-1 deficiency (primary igfd).severe primary igfd is defined by:height standard deviation score ≤ -3.0 and;basal insulin-like growth factor-1 (igf-1) levels below the 2.5th percentile for age and gender and;growth hormone (gh) sufficiency;exclusion of secondary forms of igf-1 deficiency, such as malnutrition, hypothyroidism, or chronic treatment with pharmacologic doses of anti-inflammatory steroids.severe primary igfd includes patients with mutations in the gh receptor (ghr), post-ghr signalling pathway, and igf-1 gene defects; they are not gh deficient, and therefore, they cannot be expected to respond adequately to exogenous gh treatment. it is recommended to confirm the diagnosis by conducting an igf-1 generation test.

Jaunzēlande - angļu - Medsafe (Medicines Safety Authority)

douglas pharmaceuticals limited - lansoprazole 15mg (lansoprazole (r,s racemic mixture));   - capsule - 15 mg - active: lansoprazole 15mg (lansoprazole (r,s racemic mixture))   excipient: gelatin   hypromellose macrogol 6000 mannitol meglumine methacrylic acid - ethyl acrylate copolymer polysorbate 80 purified talc purified water   quinoline yellow   sodium laurilsulfate sugar spheres titanium dioxide     - healing and long-term management of reflux oesophagitis healing and maintenance therapy for patients with duodenal ulcer healing of benign gastric ulcer lansoprazole is also effective in patients with benign peptic lesions that do not respond to h2-receptor antagonists

Jaunzēlande - angļu - Medsafe (Medicines Safety Authority)

douglas pharmaceuticals limited - lansoprazole 30mg (lansoprazole (r,s racemic mixture) );   - capsule - 30 mg - active: lansoprazole 30mg (lansoprazole (r,s racemic mixture) )   excipient: gelatin   hypromellose macrogol 6000 mannitol meglumine methacrylic acid - ethyl acrylate copolymer polysorbate 80 purified talc sodium laurilsulfate sugar spheres titanium dioxide     water   - healing and long-term management of reflux oesophagitis healing and maintenance therapy for patients with duodenal ulcer healing of benign gastric ulcer lansoprazole is also effective in patients with benign peptic lesions that do not respond to h2-receptor antagonists

Īrija - angļu - HPRA (Health Products Regulatory Authority)

pharma regulatory solutions ltd - voriconazole - pdr for soln for infusion - 200 milligram - triazole derivatives - antimycotics for systemic use, triazole derivatives - voriconazole is a broad-spectrum, triazole antifungal agent and is indicated in adults and children aged 2 years and above as follows: treatment of invasive aspergillosis. treatment of candidaemia in non-neutropenic patients. treatment of fluconazole-resistant serious invasive candida infections (including c. krusei). treatment of serious fungal infections caused by scedosporium spp. and fusarium spp. voriconazole should be administered primarily to patients with progressive, possibly life-threatening infections. prophylaxis of invasive fungal infections in high risk allogeneic hematopoietic stem cell transplant (hsct) recipients.

Filipīnas - angļu - FDA (Food And Drug Administration)

qualimed pharma, inc. (c/o united douglas pharm. phils. inc.); distributor: qualimed pharma, inc. (c/o united douglas pharm. phils. inc.) - carboplatin - solution for injection (i.v.) - 10 mg/ml (450 mg/45 ml)

Eiropas Savienība - angļu - EMA (European Medicines Agency)

mylan pharmaceuticals limited - aripiprazole - schizophrenia; bipolar disorder - psycholeptics - aripiprazole mylan pharma is indicated for the treatment of schizophrenia in adults and in adolescents aged 15 years and older.aripiprazole mylan pharma is indicated for the treatment of moderate to severe manic episodes in bipolar i disorder and for the prevention of a new manic episode in adults who experienced predominantly manic episodes and whose manic episodes responded to aripiprazole treatment.aripiprazole mylan pharma is indicated for the treatment up to 12 weeks of moderate to severe manic episodes in bipolar i disorder in adolescents aged 13 years and older.

Īrija - angļu - HPRA (Health Products Regulatory Authority)

provimi ltd - zinc oxide - premix for medicated feeding stuff - 100 percent - zinc oxide - pigs - miscellaneous

Filipīnas - angļu - FDA (Food And Drug Administration)

golden dale pharma corp. - carbocisteine , zinc - film coated tablet - 500mg / 5mg (equivalent to 13.720mg zinc sulfate monohydrate)